HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Amantadine Hydrochloride

HCID 64150
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
665-66-7
Standard SMILES
Cl.NC12CC3CC(CC(C3)C1)C2
InChIKey
WOLHOYHSEKDWQH-UHFFFAOYSA-N
Molecular formula
C10H17N.ClH
Average molar mass
187.71 g/mol
Monoisotopic mass
187.11277726

Overview

Amantadine Hydrochloride can cause developmental toxicity according to state or federal government labeling requirements.

Names & identifiers

Preferred name
Amantadine Hydrochloride
IUPAC
adamantan-1-amine;hydrochloride
English name
1-Adamantanamine hydrochloride
Molecular formula
C10H18ClN
Molecular weight
187.71

Names & synonyms

Amantadine hydrochloride665-66-71-Adamantanamine hydrochlorideAmantadine HCl1-Aminoadamantane hydrochlorideAdamantanamine hydrochlorideMantadix1-Adamantylamine hydrochlorideOsmolexExp-105-1LysovirMantadine
Show more names
symmetrel1-ADAMANTANAMINE HCLADAMANTAN-1-AMINE HYDROCHLORIDEMantadanAmantadine hydrochlorid(3s,5s,7s)-adamantan-1-amine hydrochloride
NSC-83653M6Q1EO9TD0Tricyclo(3.3.1.1(sup 3,7))decan-1-amine, hydrochlorideNSC83653CHEBI:2619Osmolex erRefChem:54147Hydrochloride, Amantadine

Database identifiers

CAS
665-66-7
PubChem CID
64150
DTXSID
DTXSID50874031
ChEMBL
CHEMBL1569
UNII
M6Q1EO9TD0
EC Number
211-560-2

Properties

Computed structural properties

Topological polar surface area
26 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
1
Rotatable bonds
0
Heavy atoms
12
Formal charge
0
Complexity
144

Experimental & physicochemical properties

Human Drugs · 3 items

Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antiparkinson Agents; Antiviral Agents; Dopamine Agents

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physical DescriptionDry Powder
Collision Cross Section138.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
300 °C · >300 °C(lit.)
Boiling point
308.63 °C · 308.63°C (rough estimate)
Density
1.0276 · 1.0276 (rough estimate)
refractive index
1.61 · 1.6100 (estimate)
storage temp.
30 °C · Store below +30°C.
solubility
2 O: · H2O: 50 mg/mL
form
Fine Crystalline Powder
pka
10.71 · 10.71

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H302 (99.5%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P318, P319, P321, P330, P363, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 210 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 5 items

Chemical: Tricyclo[3.3.1.13,7]decan-1-amine, hydrochloride

Hazard Traits - Developmental Toxicity

Tricyclo[3.3.1.13,7]decan-1-amine, hydrochloride (1:1) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Tricyclo[3.3.1.13,7]decan-1-amine, hydrochloride (1:1) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

REACH registered substance: Amantadine hydrochloride (EC: 211-560-2)

1-Adamantane ammonium chloride: Does not have an individual approval but may be used under an appropriate group standard

Hazard Classes and CategoriesAcute Tox. 4 (99.5%)

Toxicology

Treatment · 1 item

There is no specific antidote for an overdose of Amantadine. However, slowly administered intravenous physostigmine in 1 and 2 mg doses in an adult2 at 1- to 2-hour intervals and 0.5 mg doses in a child3 at 5- to 10-minute intervals up to a maximum of 2 mg/hour have been reported to be effective in the control of central nervous system toxicity caused by amantadine hydrochloride. For acute overdosing, general supportive measures should be employed along with immediate gastric lavage or induction of emesis. Fluids should be forced, and if necessary, given intravenously. The pH of the urine has been reported to influence the excretion rate of Amantadine. (L1744)

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 1 item

No appreciable metabolism, although negligible amounts of an acetyl metabolite have been identified. Amantadine is well absorbed orally from the gastrointestinal tract. The mechanism of its antiparkinsonic effect is not fully understood, but it appears to be releasing dopamine from the nerve endings of the brain cells, together with stimulation of norepinephrine response. The antiviral mechanism seems to be unrelated. The drug interferes with a viral protein, M2 (an ion channel), which is needed for the viral particle to become "uncoated" once it is taken inside the cell by endocytosis. Metabolites are excreted in the urine (A308). Route of Elimination: It is primarily excreted unchanged in the urine by glomerular filtration and tubular secretion. Half Life: Mean half-lives ranged from 10 to 14 hours, however renal function impairment causes a severe increase in half life to 7 to 10 days.

FDA Pharmacological Classification · 4 items

AMANTADINE HCL

M2 Protein Inhibitors [MoA]; Influenza A M2 Protein Inhibitor [EPC]

AMANTADINE HYDROCHLORIDE

Influenza A M2 Protein Inhibitor [EPC]; M2 Protein Inhibitors [MoA]

MeSH Pharmacological Classification · 4 items

Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.

A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS.

Uses & manufacturing

Related reactions

25 records
New reaction record
HRID 234742 reaction equation
HRID 234742As reactant
HRID 338189 reaction equation
HRID 338189As reactant
HRID 487117 reaction equation
HRID 487117As reactant
HRID 606682 reaction equation
HRID 606682As reactant
HRID 617228 reaction equation
HRID 617228As reactant
HRID 876156 reaction equation
HRID 876156As reactant
HRID 924562 reaction equation
HRID 924562As reactant
HRID 926901 reaction equation
HRID 926901As reactant
PreviousPage 1 of 4

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
color
White
Water Solubility
soluble
Sensitive
Hygroscopic
Merck
14 · 14,374
BRN
4198854 · 4198854
Major Application
pharmaceutical (small molecule)
InChI
1S/C10H17N.ClH/c11-10-4-7-1-8(5-10)3-9(2-7)6-10;/h7-9H,1-6,11H2;1H/t7-,8+,9-,10-;
InChIKey
WOLHOYHSEKDWQH-UHFFFAOYSA-N
SMILES
Cl[H].[H][C@@]12C[C@@]3([H])C[C@@]([H])(C1)CC(N)(C2)C3
LogP
-1.64 at · -1.64 at 23℃ and pH6.3
CAS DataBase Reference
665 · 665-66-7(CAS DataBase Reference)
FDA UNII
6 Q1EO9TD0 · M6Q1EO9TD0
NCI Dictionary of Cancer Terms
amantadine hydrochloride
NCI Drug Dictionary
amantadine hydrochloride
Proposition 65 List
Amantadine Hydrochloride
EPA Substance Registry System
Amantadine hydrochloride (665-66-7)
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Protein binding
67 % · 67%
Excreted unchanged in urine
90 % · 90%
Volume of distribution
5 · 5-10(L/kg)
Biological half-life
15 · 15 / 500
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302
Precautionary statements
301 · P301+P312+P330
Hazard Codes
Xn
Risk Statements
22 · 22-40-20/21/22
Safety Statements
22 · 22-36/37-36-35-20/21
RIDADR
1759 · UN 1759 8 / PGII
WGK Germany
3 · 3
RTECS
4375000 · AU4375000
TSCA
TSCA listed
HazardClass
IRRITANT
HS Code
29213000 · 29213000
Storage Class
8 A · 8A - Combustible corrosive hazardous materials
Hazard Classifications
4 Oral · Acute Tox. 4 Oral
Toxicity
50 orally · LD50 orally in mice, rats: 700, 1275 mg/kg (Vernier)
REACH Registrations
Active
Health Effects · 1 item

Acute overdosage of amantadine has resulted in cardiac dysfunction (e.g., arrhythmia, tachycardia, hypertension); pulmonary edema and respiratory distress (including adult respiratory distress syndrome); renal dysfunction (e.g., increased BUN, decreased creatinine clearance, renal insufficiency); or CNS toxicity (e.g., insomnia, anxiety, psychotic reactions, lethargy, somnolence, coma). Hyperthermia also has occurred with amantadine overdosage. In addition, seizures may be exacerbated in patients with a history of a seizure disorder (A620).

Exposure RoutesInhalation. Amantadine is well absorbed orally from the gastrointestinal tract.
Toxicity Summary · 1 item

The mechanism of its antiparkinsonic effect is not fully understood, but it appears to be releasing dopamine from the nerve endings of the brain cells, together with stimulation of norepinephrine response. It also has NMDA receptor antagonistic effects. The antiviral mechanism seems to be unrelated. The drug interferes with a viral protein, M2 (an ion channel), which is needed for the viral particle to become "uncoated" once it is taken inside the cell by endocytosis.

Signs and Symptoms · 1 item

Deaths have been reported from overdose with amantadine. The lowest reported acute lethal dose was 2 grams. Drug overdose has resulted in cardiac, respiratory, renal or central nervous system toxicity. Cardiac dysfunction includes arrhythmia, tachycardia and hypertension. Pulmonary edema and respiratory distress (including ARDS) have been reported. Renal dysfunction including increased BUN, decreased creatinine clearance and renal insufficiency can occur. Central nervous system effects that have been reported include insomnia, anxiety, aggressive behavior, hypertonia, hyperkinesia, tremor, confusion, disorientation, depersonalization, fear, delirium, hallucination, psychotic reactions, lethargy, somnolence and coma. Seizures may be exacerbated in patients with prior history of seizure disorders. Hyperthermia has also been observed in cases where a drug overdose has occurred.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Amantadine hydrochloride

Ambiguous-DILI-concern

3

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Toxicity DataLD50: 800 mg/kg (Oral, Rat) LD50: 700 mg/kg (Oral, Mouse)

Safety data

wgk
3
tsca
TSCA listed
rtecs
AU4375000
ridadr
UN 1759 8 / PGII
hs_code
29213000
Toxicity
LD50 orally in mice, rats: 700, 1275 mg/kg (Vernier)
risk_code
22-40-20/21/22
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
safety_code
22-36/37-36-35-20/21
hazard_class
IRRITANT
Storage Class
8A - Combustible corrosive hazardous materials
Hazard statements
H302
REACH Registrations
Active
Hazard Classifications
Acute Tox. 4 Oral
Precautionary statements
P301+P312+P330
UsesFor the chemoprophylaxis, prophylaxis, and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Also for the treatment of parkinsonism and drug-induced extrapyramidal reactions (A308).
U.S. Production2021: 250,000 - <550,000 lb
Industry UsesProcessing aids not otherwise specified
General Manufacturing Information · 2 items

All Other Basic Organic Chemical Manufacturing

Tricyclo[3.3.1.13,7]decan-1-amine, hydrochloride (1:1): ACTIVE

Applications · 5 items

Uses1-Adamantanamine hydrochloride is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extra pyramidal reactions, and for postherpetic neuralgia. It is also used an NMDA-receptor antagoinst.

Usesantiviral, antiparkinsonian; treatment of drug-induced extrapyrimidal reactions

Usesselective FP prostanoid receptor agonist, F-series prostaglandin analog. 200 times as potent as Latanoprost -20oC

UsesNMDA-receptor antagonist. Antiviral; antiparkinsonian

General DescriptionPharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

Upstream & downstream products

Upstream raw materials

Aluminium-nickelAmantadineDicyclopentadieneSodium sulfiteChlorineUreaAluminum chlorideHydrochloric acidHydrogenBromineSodium hydroxideHydrogen cyanideAdamantane2-Adamantanamine hydrochloride

Additional notes

DefinitionChEBI: A hydrochloride obtained by combining amantadine and hydrochloric acid in equimolar amounts.